Tomasz Skorski

Temple University

NIH Rank #2860
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.9M
Fiscal year 2024
Grants Awarded
6
Active NIH grants
National Rank
#2,860
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.9M across 6 grants · National rank #2860.

Top grants by award amount

Tomasz Skorski's NIH grant portfolio, ranked by award amount.

  • 5R01CA283396-02R01
    Divergent Functions of ERK Substrate Binding Domains in Pathogenesis of Myeloproliferative Neoplasms
    $671.7K
    award amount
  • 5R01CA237286-05R01
    AML mutation-guided drugging of DNA repair
    $523.1K
    award amount
  • 5R01CA244179-05R01
    PolQ as a novel therapeutic target in AML
    $499.9K
    award amount
  • 5R01CA247707-05R01
    MPN-inducing mutations as biomarkers of synthetic lethality
    $406.9K
    award amount
  • 5R01CA244044-05R01
    Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors
    $387.3K
    award amount
  • 5R01CA186238-10R01
    Targeting DNA repair to eradicate TKi-refractory/resistant CML and Ph+ALL
    $377.6K
    award amount

Affiliations

Institutions that have administered grants for Tomasz Skorski.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Temple University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2860
  6. 2024
    Entered Top 25% Nationally
    Ranked #2860
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions